OFDT's working organization
Units
The French Monitoring Centre is organised into four scientific units and two transversal supporting units:
Scientific units:
- Indicators
- Surveys and Statistical Analysis
- Emerging Trends and New Drugs
- Public Policy Evaluation
Transversal units:
- Information and Communication
- Financial and Human Resources
Our organisational breakdown is detailed below on the chart. To see "who's who" in our permanent staff click here.
Organisational chart (January 2020)
Management Board
Chairperson:
Christine d'AUTUME
Vice-Chairperson:
Nicolas PRISSE, MD
Scientific College
Chairperson:
Bruno FALISSARD, MD, PhD
Julien
MOREL d'ARLEUX
Director
Ivana
OBRADOVIC
Deputy director
Julie-Émilie ADÈS
Media relations
General Matters
Virginie
MARTIN
Head of General Matters
Administration
Mickaël
DA SILVA
Assistant
Indicators
Christophe
PALLE
Head of unit
Anne-Claire
BRISACIER
Project manager
Marc-Antoine
DOUCHET
Project manager
Surveys and Statistical Analysis
Stanislas
SPILKA
Head of unit
Eric
JANSSEN
Project manager
Olivier
LE NÉZET
Project manager
Antoine
PHILIPPON
Project manager
Aurélia
ROVERSI
Project manager
Public Policy Evaluation
Cristina
DĺAZ-GÓMEZ
Head of unit
Maïtena
MILHET
Project manager
Carine
MUTATAYI
Project manager
Caroline
PROTAIS
Project manager
Emerging Trends and New Drugs
Agnès
CADET TAÏROU
Head of unit
Victor
DETREZ
Chargé d’études
Michel
GANDILHON
Project manager
Clément
GÉROME
Project Manager
Magali
MARTINEZ
Project manager
Information and Communication
Julie-Émilie
ADÈS
Head of unit
Thierry
DELPRAT
Webmaster
Anne
de l’EPREVIER
Documentalist
Isabelle
MICHOT
Documentalist
Frédérique
MILLION
Graphic designer
Financial and Human Resources
Pierre
PIQUEMAL-LAGORRE
Accountant
Laurence
GRANDJEAN
Deputy accountant
Mickaël
DA SILVA
Accounting assistant
Drugs in Europe
2019 EMCDDA European Drug Report
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
